BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
26 results:

  • 1. pou5f1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6.
    Yang W; Cui X; Sun D; Sun G; Yan Z; Wei M; Wang Z; Yu W
    Cell Death Dis; 2023 Dec; 14(12):802. PubMed ID: 38062041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
    Zhao H; Jiang R; Feng Z; Wang X; Zhang C
    J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rspondin-1 contributes to the progression and stemness of gastric cancer by LGR5.
    Wang C; Gao Y; Liang W; Lu Y; Zhang K; Wu D; Zhuang Z; Li K; Qiao Z; Xi H; Chen L
    Biochem Biophys Res Commun; 2022 Oct; 627():91-96. PubMed ID: 36030657
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. oct4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
    Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
    Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of NOTCH1 and oct4 in gastric carcinoma.
    Ibrahim DA; Elsebai EA; Fayed A; Abdelrahman AE
    Indian J Pathol Microbiol; 2022; 65(2):328-335. PubMed ID: 35435367
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
    Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
    Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
    El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
    J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DDIT3 modulates cancer stemness in gastric cancer by directly regulating CEBPβ.
    Lin H; Liu S; Gao W; Liu H
    J Pharm Pharmacol; 2020 Jun; 72(6):807-815. PubMed ID: 32189359
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
    Peng C; Huang K; Liu G; Li Y; Yu C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1711-1719. PubMed ID: 30843262
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis.
    Wei Y; Liu H; Wang C; Zhang W; Wen X; Long H; Xu Z; Guo H; Liu Y; Wei D; Qiu C; Li G; Sun Z
    Biomark Med; 2019 Feb; 13(3):219-234. PubMed ID: 30810340
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of High Expression Levels of SOX2, NANOG, and oct4 in gastric cancer Tumor Tissues with Progression and Poor prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Differential expression of two genes Oct-4 and MUC5AC associates with poor outcome in patients with gastric cancer.
    Javanbakht M; Akhavanmoghadam J; Talaei AJ; Aghyani M; Mozafari M; Khedmat L; Mohebbi M
    Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1099-1105. PubMed ID: 28762513
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. gastric cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
    Yamazawa S; Ushiku T; Shinozaki-Ushiku A; Hayashi A; Iwasaki A; Abe H; Tagashira A; Yamashita H; Seto Y; Aburatani H; Fukayama M
    Am J Surg Pathol; 2017 Jul; 41(7):989-997. PubMed ID: 28505005
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
    Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
    Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.
    Wang XF; Zhang XW; Hua RX; Du YQ; Huang MZ; Liu Y; Cheng YF; Guo WJ
    Oncotarget; 2016 Sep; 7(39):63352-63361. PubMed ID: 27542229
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.
    Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W
    Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High expression of oct4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia.
    Yin JY; Tang Q; Zhai LL; Zhou LY; Qian J; Lin J; Wen XM; Zhou JD; Zhang YY; Zhu XW; Deng ZQ
    Tumour Biol; 2015 Dec; 36(12):9711-6. PubMed ID: 26152287
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical significance of pou5f1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection.
    Shen L; Du M; Wang C; Gu D; Wang M; Zhang Q; Zhao T; Zhang X; Tan Y; Huo X; Gong W; Xu Z; Chen J; Zhang Z
    Int J Mol Sci; 2014 Jul; 15(7):12764-77. PubMed ID: 25046748
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.